MARINA KONOPLEVA to MAP Kinase Kinase 1
This is a "connection" page, showing publications MARINA KONOPLEVA has written about MAP Kinase Kinase 1.
Connection Strength
0.252
-
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study. Clin Lymphoma Myeloma Leuk. 2019 07; 19(7):431-440.e13.
Score: 0.156
-
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies. J Mol Med (Berl). 2012 Oct; 90(10):1133-44.
Score: 0.096